Cite
HARVARD Citation
Stainsby, C. et al. (2019). Abacavir Hypersensitivity Reaction Reporting Rates During a Decade of HLA‐B*5701 Screening as a Risk‐Mitigation Measure. Pharmacotherapy. 39 (1), pp. 40-54. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Stainsby, C. et al. (2019). Abacavir Hypersensitivity Reaction Reporting Rates During a Decade of HLA‐B*5701 Screening as a Risk‐Mitigation Measure. Pharmacotherapy. 39 (1), pp. 40-54. [Online].